Healthcare policy

Healthcare policy focuses on public health and public healthcare provision. Access to prevention and early identification services and to appropriate healthcare for all sectors of the population is an important basic requirement. Further topics include quality assurance of the services provided and the financial viability, data situation and manageability of the healthcare system.

21.02.2019

“We are already holding the instrument in our hands”

In an age when healthcare costs are rising and the number of people with chronic diseases is growing, Switzerland is trying to reverse the trend by adopting a Health in All Policies (HiAP) approach. Ilona Kickbusch is one of the world’s foremost experts in the field. As part of this interview, she tells us what Switzerland could do better. more

21.02.2019

Developing a shared understanding of health

It takes more than just health policy to improve the health of the population. This is because many of the factors that influence health lie outside the healthcare system. A comprehensive approach driven by partnership between the FOPH and other federal offices and agencies is essential. Most importantly, all stakeholders need to develop a shared understanding of what health means. more

23.10.2018

At first hand

Communicating credibly. Communication in the healthcare sector covers a wide spectrum of activities, ranging from the doctor-patient conversation to public health prevention campaigns. But one rule is common to all: successful communication relies on the existence of trust. more

06.09.2018

Can mHealth deliver greater health equity?

Digital disadvantage. The widespread adoption of smartphones in all sectors of the population gives some idea of the potential that could be harnessed for health promotion and prevention purposes. However, owning a smartphone does not always equate with being able to make adequate use of mHealth apps. more

06.09.2018

mHealth – what opportunities are there for mobile apps in the healthcare system?

Digital change is having a profound impact on our everyday life. The smartphone is further accelerating this process. It is a constant and ubiquitous presence, and is being increasingly used in prevention and health promotion (to measure fitness and health data) as well as in everyday medical practice (measurement of vital data, coordination and disease management). Compared with other economic sectors, however, the use of apps in the medical field has some catching up to do, not least because of the more stringent requirements regarding security and protection of health-specific data. We have sought to provide you below with an insight into the possible uses of mobile health and the challenges it faces. more

06.09.2018

"The people affected are too little aware of current data protection rules»

Interview with Barbara Widmer. Our health data are particularly sensitive, yet today everyone and everything is tracked. Can we still protect the data that mHealth apps acquire from us and store? In our discussion, the lawyer and expert on data protection issues tells us where the greatest data protection risks lie with mHealth apps and what we can still do to make our data more secure. more

07.05.2018

Federal government commitment to people with rare diseases

Rare diseases. In Switzerland some 500 000 people suffer from a rare disease. Between 7 000 and 8 000 such diseases exist. There are so many of them that they account for a quarter of illnesses worldwide and are thus as frequent as one of the most widespread diseases. How- ever, the lower the number of people suffering from a particular disease, the less we know about its causes, symptoms and treatment options. more

07.05.2018

At first hand

When the talk is of "rare diseases", we do not usually feel directly addressed: anything "rare" just affects others. But it is only the individual diseases that are rare. As a group, they are as common as diabetes. I too realised this only when we began drafting the National Rare Disease Policy. more

07.05.2018

When does the statutory health insurance (SHI) cover the costs, when does it not?

Genetic testing. Many rare diseases are of genetic origin, i.e. they can be inherited. Changes in an individual’s genetic make-up can now be demonstrated in the blood. Genetic analyses have to be accompanied by genetic counselling. However, the statutory health insurance (SHI) does not cover the often considerable cost of genetic testing in all cases. more

07.05.2018

National policy – participation in international networks

International. In order to remain involved internationally in research, diagnosis, treatment and management of rare diseases, Swiss centres of excellence rely on international partnerships. A new "International Networking" subproject in the context of the National Rare Disease Policy has been developed to help provide Swiss centres an anchor for their international integration. more